Related Experiment Video
Updated: Oct 10, 2026

Caspase-3 Activity in the Rat Amygdala Measured by Spectrofluorometry After Myocardial Infarction
Published on: January 12, 2016
TGF-beta1 inhibits caspase-3 activation and neuronal apoptosis in rat hippocampal cultures
Y Zhu1, B Ahlemeyer, E Bauerbach
1Institut für Pharmakologie und Toxikologie, Philipps-Universität Marburg, Ketzerbach 63, D-35032, Marburg, Germany. zhu@mailer.uni-marburg.de
Abstract:
The effect of TGF-beta1 on apoptosis varies depending on the cell type, the kind of stimulus and the experimental conditions. The present study attempted to identify whether TGF-beta1 can prevent neuronal apoptosis and interrupt caspase-3 activation in rat primary hippocampal cultures after staurosporine treatment. TGF-beta1 at the concentration of 1 and 10 ng/ml significantly reduced neuronal damage as detected by trypan blue exclusion. Nuclear staining with Hoechst 33258 and TUNEL-staining further demonstrated that TGF-beta1 at the same concentration range effectively diminished neuronal apoptosis 24 h after staurosporine treatment, whereas 0.1 ng/ml of TGF-beta1 did not. Furthermore, TGF-beta1 (1 and 10 ng/ml) markedly inhibited the activation of caspase-3 induced by staurosporine as demonstrated by both caspase-3 activity assay and Western blotting. This study provides evidence that TGF-beta1 is able to efficiently inhibit caspase-3 activation, and thereby protects cultured hippocampal neurons against apoptosis.
Insights
Transforming Growth Factor-beta1 (TGF-beta1) prevents neuronal apoptosis and inhibits caspase-3 activation in rat hippocampal cultures. This neuroprotective effect was observed after staurosporine treatment.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Apoptosis, or programmed cell death, is a critical process in neuronal development and survival.
- Transforming Growth Factor-beta1 (TGF-beta1) has varied effects on apoptosis depending on cell type and experimental context.
- Neuronal apoptosis is implicated in various neurological disorders.
Purpose of the Study:
- To investigate the potential of TGF-beta1 to prevent apoptosis in rat primary hippocampal neurons.
- To determine if TGF-beta1 can inhibit caspase-3 activation induced by staurosporine.
- To elucidate the role of TGF-beta1 in neuronal protection against apoptotic stimuli.
Main Methods:
- Primary hippocampal cultures from rats were treated with staurosporine to induce apoptosis.
- Cells were co-treated with varying concentrations of TGF-beta1 (0.1, 1, and 10 ng/ml).
- Neuronal damage was assessed using trypan blue exclusion, Hoechst 33258 nuclear staining, and TUNEL assay.
- Caspase-3 activation was measured via activity assays and Western blotting.
Main Results:
- TGF-beta1 at 1 and 10 ng/ml significantly reduced neuronal damage and apoptosis following staurosporine treatment.
- Lower concentration (0.1 ng/ml) of TGF-beta1 did not show significant protective effects.
- TGF-beta1 (1 and 10 ng/ml) markedly inhibited staurosporine-induced caspase-3 activation at both activity and protein levels.
Conclusions:
- TGF-beta1 exhibits significant neuroprotective properties against staurosporine-induced apoptosis in hippocampal neurons.
- The neuroprotection is mediated by the inhibition of caspase-3 activation.
- These findings highlight TGF-beta1 as a potential therapeutic agent for conditions involving neuronal apoptosis.
Related Concept Videos
Caspases
TGF - β Signaling Pathway
